NCT05859802: Effects of Physical Therapy and Dalfampridine on Functional Mobility in Non Ambulatory Persons With Multiple Sclerosis |
|
|
| Completed | 2/3 | 35 | NA | Dalfampridine Pill, Physical Therapy, Placebo | D'Youville College, Acorda Therapeutics, University at Buffalo | Multiple Sclerosis | 03/15 | 01/16 | | |
2020-002438-34: Fampridine for treatment of functional disability in patients with immune mediated polyneuropathy |
|
|
| Not yet recruiting | 2 | 40 | Europe | Fampyra, Tablet, Fampyra | Department of Neurology, Odense University Hospital, Novo Nordisk Foundation | Chronic inflammatory demyelinating polyneuropathy, Immune mediated polyneuropathy, Diseases [C] - Nervous System Diseases [C10] | | | | |